Dr. Shankar Alegaon View Publications

Shankar Alegaon

Dr. Shankar Alegaon

Professor & Head, Dept. of Pharmaceutical Chemistry

+91 831 2471399
Department of Pharmaceutical Chemistry KLE College of Pharmacy, Karnataka, Belagavi, Karnataka, India - 590 010

Experience and Background

Graduation B.Pharm
Specialization Pharmacy
Post Graduation M.Pharm
Specialization Pharmaceutical chemistry
PhD and Others Ph.D
Specialization Pharmaceutical chemistry
Teaching Experience(Total Years) 15
Research Experience(Total Years) 14
Industry Experience(Total Years) None
Teaching (Graduate level) Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Analysis
Teaching (Post-Graduate level) Modern Pharmaceutical Analysis, Advanced Spectral Analysis and CADD
Projects Carried 13
Total Papers published 20
Patents -
Total Papers Presented 11


1. Shankar G Alegaon_CV

2. Synthesis, characterization and antimicrobial activity evaluation of new 2,4-Thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety

3. Microwave-Assisted Synthesis, Antimicrobial and Cytotoxic Activities of Some 4-Thioxo-Thiazolidine-2-One Derivatives

4. New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties

5. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents

6. New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent

7. Synthesis, characterization, and biological evaluation of thiazolidine-2,4-dione derivatives

8. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives

9. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents

10. Synthesis, pharmacophore modeling, and cytotoxic activity of 2-thioxothiazolidin-4- one derivatives

11. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

12. Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines

13. Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors

14. Synthesis and biological evaluation of 1,3,4-trisubstituted pyrazole analogues as anti-mycobacterial agents

15. Synthesis of new 7-chloro-4-phenoxyquinoline analogues as potential antitubercular agents

16. Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents

17. Design and synthesis of new 3-((7- chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors

18. Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents